FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Protalix BioTherapeutics, Inc.: accounts_receivable

One fact, its scope and the complete path back to the official record.

Period: as of 2025-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/59578620-7849-45c2-b5d0-ef2dfa0b0378

Reported value

$8.840M{"amount": 8840000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Entity
Protalix BioTherapeutics, Inc.
Metric
accounts_receivable
Period
as of 2025-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001104659-26-029858 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T09:46:40.106229+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001006281/accounts-receivable/2025-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.